C
BLUE

Covestor’s bluebird bio BLUE Stock Holding History

Covestor’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1
Closed – – 2115
2021
Q4 		$0 Buy
+1
New +$236 ﹤0.01% 2119

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Covestor's BLUE Position: Q1 2022 in Review

Covestor sold out of bluebird bio (BLUE) in Q1 2022, closing a stake of 1 share.

Covestor first reported a position in BLUE in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 174 funds tracked by Wall St. Rank hold BLUE as of Q1 2022.

  • Covestor reported no remaining bluebird bio position as of Q1 2022 after selling out during the quarter.
  • Covestor sold 1 bluebird bio share in Q1 2022.
  • Covestor first reported a position in bluebird bio in Q4 2021 and held it in 1 quarter.
  • Covestor's bluebird bio position peaked at $0 in Q4 2021.
  • 174 funds tracked by Wall St. Rank held bluebird bio as of Q1 2022.

Based on Covestor's 13F filing for Q1 2022, filed 13 May 2022.